XNYS
METpA
Market cap58bUSD
Jul 09, Last price
21.25USD
1D
0.09%
1Q
2.26%
Jan 2017
-8.72%
IPO
-10.71%
Name
MetLife Inc
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MetLife, Inc., a global financial services enterprise headquartered in New York, New York, and established in 1863, delivers a broad spectrum of solutions, encompassing insurance, annuities, employee benefits, and asset management services to clients worldwide. Its operations are structured across five key segments: the U.S., Asia, Latin America, Europe, the Middle East and Africa, and MetLife Holdings. MetLife's extensive insurance offerings include individual and group life, dental, vision, pet, accident and health, and accidental death and dismemberment coverages. It also provides various disability plans (short-term, long-term, and individual), prepaid legal services, and administrative services-only arrangements for corporate clients. Beyond traditional protection, the company offers a diverse portfolio of savings and investment vehicles. These range from fixed, indexed-linked, and variable annuities to pension and regular savings products. It manages general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. MetLife also specializes in pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products. Further services include funding agreements for post-retirement benefits, along with company, bank, or trust-owned life insurance designed to finance non-qualified executive benefit programs. The product suite is rounded out by endowments, universal and variable life policies, group life insurance, longevity reinsurance, credit insurance, and long-term healthcare protection plans.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||